Kellerhals Carrard has advised Swiss biotech startup Alp Bio AG on all legal aspects of a USD 2.2 million pre-seed funding round led by Munich-based 42CAP, with participation from Venture Kick and strategic angel investors.
Tags :Dario Silberschmidt
Kellerhals Carrard advised Zurich-based AI startup Lobby throughout completion of a USD 2.2 million financing round, led by Founderful. The company has built an AI platform that interprets inbound requests, assembles offers, and manages the downstream
Kellerhals Carrard advised Seprify on a CHF 12.25 million series A financing round. Headquartered in Marly, Seprify engineers cellulose at the micro- and nano-scale to create materials capable of replacing titanium dioxide (TiO₂). Una Terra Early
Kellerhals Carrard advised Kaspar&, a specialist in white-label and B2B solutions for financial institutions, on the sale of all shares in the company to Liberty Vorsorge, a Swiss independent provider of pension and
Kellerhals Carrard advised ScyAI, as the Swiss risk intelligence startup accessed an early €2 million financing. Headquartered in Zurich, ScyAI operates a platform that translates complex hazard and climate data into granular, asset-level risk intelligence. AENU
MLL Legal advised Chiral, a Swiss nanotechnology company specialising in semiconductor and quantum technologies with nanomaterials, throughout closing of a $12 million seed financing round. Moreover, a Kellerhals Carrard team from the firm startup & VC
Kellerhals Carrard advised Gravis Robotics — a Zurich-based construction-tech company Founded in 2022 at ETH Zurich — throughout its USD 23 million financing round. IQ Capital and Zacua Ventures co-led the round in question, with further support from Pear
Kellerhals Carrard advised FenX – a Swiss cleantech company and ETH spin-off transforming waste into green insulation materials – throughout its Series A financing round. Raising CHF 8.2 million, the round saw participation from lead investors Supernova Invest
Kellerhals Carrard advised Positrigo throughout its latest financing round. Raising an amount of CHF 7 million, the round in question was led by HealthCap, with participation from Navivo Capital as well as several family offices
Kellerhals Carrard advised Oxyle, a cleantech spinoff company of ETH Zurich, through successful completion of a $16 million seed financing round. 360 Capital led the capital round in question, with additional support from Axeleo Capital, and returning
